Fifth Third Bancorp »

Tvardi Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $3 1 3.00

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
Vanguard Capital Management
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Silvercrest Asset Management Group
Morgan Stanley
Duncan Williams Asset Management
UBS Group
Northern Trust
Vanguard Fiduciary Trust
Farallon Capital Management

View all funds holding Tvardi Therapeutics